Dr John Cash established the SNBTS Coagulation Factor Study Group. Read more about Dr John Cash established the SNBTS Coagulation Factor Study Group.
Dr Peter Foster was shocked when Dr John Cash told him that the German company Behringwerke had announced at a symposium in Bonn that it was pasteurising Factor 8, as he had thought heat could not be used to inactivate virus in factor products. Read more about Dr Peter Foster was shocked when Dr John Cash told him that the German company Behringwerke had announced at a symposium in Bonn that it was pasteurising Factor 8, as he had thought heat could not be used to inactivate virus in factor products.
Milt Mozen visited SNBTS PFC and discussed the issue of hepatitis with Jim Smith. Read more about Milt Mozen visited SNBTS PFC and discussed the issue of hepatitis with Jim Smith.
A clinical trial of 8Y was reported to be at a stage where several patients had safely passed the point at which first evidence of non-A non-B Hepatitis transmission would have been expected. Read more about A clinical trial of 8Y was reported to be at a stage where several patients had safely passed the point at which first evidence of non-A non-B Hepatitis transmission would have been expected.
J K Smith, Lowell Winkelman and P A Feldman reported the interim results that severe heating had been more effective in preventing transmission of non-A non-B Hepatitis than the milder heating given to at least two US commercial products. Read more about J K Smith, Lowell Winkelman and P A Feldman reported the interim results that severe heating had been more effective in preventing transmission of non-A non-B Hepatitis than the milder heating given to at least two US commercial products.
Dr Shanbrom had suggested to the executives that they should no longer take plasma from hepatitis hotspots such as downtown Los Angeles and from prisons because of the risks. Read more about Dr Shanbrom had suggested to the executives that they should no longer take plasma from hepatitis hotspots such as downtown Los Angeles and from prisons because of the risks.
Clive Collins stated that ,"Given the specialised medical nature of the seroconversion problem it was appropriate that my Medical Department colleagues dealt directly with the DHSS Medical staff." Read more about Clive Collins stated that ,"Given the specialised medical nature of the seroconversion problem it was appropriate that my Medical Department colleagues dealt directly with the DHSS Medical staff."
Dr Peter Fernandes stated that similar stabilisers to those which worked with the globulin could work with antihemophilic factor. Read more about Dr Peter Fernandes stated that similar stabilisers to those which worked with the globulin could work with antihemophilic factor.
Dr Milton Mozen, the director of biochemical research and development at Cutter, emphasised in his evidence to the Institute of Medicine in the US that a heat treatment process is successful as applied by one manufacturer, it does not follow that this process would be applicable to the unique products of the other manufacturer. Read more about Dr Milton Mozen, the director of biochemical research and development at Cutter, emphasised in his evidence to the Institute of Medicine in the US that a heat treatment process is successful as applied by one manufacturer, it does not follow that this process would be applicable to the unique products of the other manufacturer.
Some Factor 8 product had been recalled, but this was probably a batch recall rather than a general recall. Read more about Some Factor 8 product had been recalled, but this was probably a batch recall rather than a general recall.